U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07832513) titled 'Study of Pregnancy in Patients With Myeloproliferative Neoplasms' on Sept. 16.
Brief Summary: This is a study to evaluate pregnancy in patients with myeloproliferative neoplasms. The main endpoint of this study is to determine the number of live births in pregnant MPN patients who are managed by a risk-adapted algorithm
Study Start Date: Oct. 05
Study Type: OBSERVATIONAL
Condition:
Myeloproliferative Neoplasm (MPN)
Pregnancy
Intervention:
OTHER: Risk-adapted algorithm
The risk-based algorithm is based on expert consensus and has been well-described in review articles and educational sessions at major conferences.
Recruitmen...